Stockscreener 앱 받기
1.86
4.49%
0.08
시간 외 거래:
1.90
0.04
+2.15%
전일 마감가:
$1.78
열려 있는:
$1.76
하루 거래량:
3.86M
Relative Volume:
3.54
시가총액:
$182.15M
수익:
$97.06M
순이익/손실:
$-130.39M
주가수익비율:
-1.0814
EPS:
-1.72
순현금흐름:
$-186.54M
1주 성능:
-5.58%
1개월 성능:
-48.83%
6개월 성능:
-55.61%
1년 성능:
-76.40%
1일 변동 폭
$1.725
$1.885
1주일 범위
$1.725
$2.02
52주 변동 폭
$1.725
$8.90
알렉터 Stock (ALEC) Company Profile
명칭
Alector Inc
전화
415-231-5660
주소
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
ALEC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.86 | 182.15M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
알렉터 Stock (ALEC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-11-29 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-26 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-09-25 | 개시 | Goldman | Sell |
| 2023-09-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-09-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-04-13 | 개시 | Goldman | Sell |
| 2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-27 | 개시 | William Blair | Outperform |
| 2021-01-15 | 재개 | BofA Securities | Buy |
| 2020-06-24 | 개시 | H.C. Wainwright | Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-06 | 개시 | Citigroup | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-02-19 | 개시 | Stifel | Buy |
| 2019-11-21 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | Barclays | Overweight |
| 2019-03-04 | 개시 | BofA/Merrill | Buy |
| 2019-03-04 | 개시 | Morgan Stanley | Overweight |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
모두보기
알렉터 주식(ALEC)의 최신 뉴스
Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Alector stock hits 52-week low at $1.73 amid market challenges - Investing.com Australia
Alector (NASDAQ:ALEC) Rating Lowered to “Neutral” at Mizuho - Defense World
BNP Paribas Financial Markets Cuts Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Rating Lowered by Mizuho - MarketBeat
Alector stock under pressure as key AL002 program removed—Mizuho - Investing.com
Alector stock under pressure as key AL002 program removed—Mizuho By Investing.com - Investing.com UK
Alector Inc. stock downgraded to Hold by Stifel, amid mixed biotechnology outlook - Investing.com Australia
Alector (NASDAQ:ALEC) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Stifel Downgrades Alector (ALEC) - MSN
Verition Fund Management LLC Sells 473,794 Shares of Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Alector stock hits 52-week low at $1.99 amid market challenges - Investing.com Australia
Short Interest in Alector, Inc. (NASDAQ:ALEC) Grows By 34.1% - MarketBeat
Alector, Inc. (NASDAQ:ALEC) Sees Large Growth in Short Interest - Defense World
Alector (ALEC) Stock Dips Amid Biotech Sector Volatility - GuruFocus.com
Point72 Asset Management L.P. Sells 529,847 Shares of Alector, Inc. (NASDAQ:ALEC) - MarketBeat
RA Capital Management, L.P. Acquires Significant Stake in Alecto - GuruFocus.com
Bank of America Downgrades Alector (NASDAQ:ALEC) to Underperform - Defense World
Alector downgraded to Underperform at BofA after Alzheimer's trial miss - MSN
Alector stock hits 52-week low at $2.36 amid market challenges - Investing.com Canada
Neurology-Focused Alector Downgraded On Failed Alzheimer's Study, BofA Securities Highlights Lack Of Catalysts - Benzinga
Alector (NASDAQ:ALEC) Downgraded to Underperform Rating by Bank of America - MarketBeat
Alector CFO Marc Grasso sells $41,542 in stock By Investing.com - Investing.com Canada
Alector's chief medical officer sells shares worth $37,518 By Investing.com - Investing.com Canada
Alector's chief medical officer sells shares worth $37,518 - Investing.com
Alector president and head of R&D sells $66,764 in stock - Investing.com
Alector president and head of R&D sells $66,764 in stock By Investing.com - Investing.com Canada
Alector CEO Rosenthal sells over $131,000 in stock - Investing.com
Alector CFO Marc Grasso sells $41,542 in stock - Investing.com
Alector CEO Rosenthal sells over $131,000 in stock By Investing.com - Investing.com UK
Deutsche Bank Initiates Coverage of Alector (ALEC) with Buy Recommendation - MSN
Vigil Neuroscience: Down On A Competitor's Failure (NASDAQ:VIGL) - Seeking Alpha
Alector (ALEC) Stock Drops 5.02% Amidst Market Volatility - GuruFocus.com
HC Wainwright Issues Pessimistic Forecast for Alector (NASDAQ:ALEC) Stock Price - Defense World
Braidwell LP Has $10.06 Million Stock Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
HC Wainwright Cuts Alector (NASDAQ:ALEC) Price Target to $7.00 - MarketBeat
Q1 Earnings Estimate for Alector Issued By HC Wainwright - MarketBeat
Need To Know: Analysts Just Made A Substantial Cut To Their Alector, Inc. (NASDAQ:ALEC) Estimates - Simply Wall St
Victory Capital Management Inc. Increases Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Rating Lowered by Morgan Stanley - Defense World
Alector shares price target cut, retains buy amid clinical trial setback - Investing.com Australia
Alector: Bleak Prospects After Alzheimer's Failure (NASDAQ:ALEC) - Seeking Alpha
ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study - Yahoo Finance
Alector price target lowered to $7 from $35 at H.C. Wainwright - Yahoo Finance
Alector AL002 INVOKE-2 Phase II Alzheimer’s trial misses goal - The Pharma Letter
Alector (NASDAQ:ALEC) Given New $5.00 Price Target at BTIG Research - Defense World
Alector stock hits 52-week low at $2.61 amid market challenges - Investing.com Canada
알렉터 (ALEC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
알렉터 주식 (ALEC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Dec 02 '24 |
Sale |
2.52 |
52,172 |
131,442 |
2,507,074 |
| Kenkare-Mitra Sara | President and Head of R&D |
Dec 02 '24 |
Sale |
2.52 |
26,500 |
66,764 |
565,215 |
| Romano Gary | Chief Medical Officer |
Dec 02 '24 |
Sale |
2.52 |
14,892 |
37,519 |
349,283 |
2.88%
2.65%
자본화:
|
볼륨(24시간):